جست‌وجوی استاد و پژوهشگر

Per Medbøe Thorsbyمشاهده پروفایل

دانشیار

• Endocrinology
• Diabetes
• Hormone Diagnostics
• +۷ مورد دیگر

Per Medbøe Thorsby is an Associate Professor in the Department of Medical Biochemistry at the Faculty of Medicine, University of Oslo. He is medically responsible for the Hormone Laboratory at Aker Hospital, Oslo University Hospital, and actively engaged in clinical and research activities in endocrinology and metabolism. Research Interests: Diagnosis and management of endocrine diseases Diabetes and metabolic disorders Adrenal, thyroid, and pediatric endocrinology Gynecological endocrinology Anti-doping in sports Vitamin D and bone health Steroid hormone analysis using LC-MS/MS His recent publications (2023–2025) reflect a strong focus on endocrinology, clinical biochemistry, and metabolic health. Key themes include: Development and validation of advanced analytical methods (LC-MS/MS) for steroid and thyroid hormone measurement Investigations into vitamin D metabolism in pregnancy, children, and metabolic disease Cardiovascular and neurological effects of anabolic steroid use Autoimmune aspects of narcolepsy and related disorders Bone health in diabetes and rare metabolic conditions Scientific Awards and Recognition: No specific awards listed in the provided text. Advising and Grants: Course manager for laboratory courses in endocrinology since 2008 Teaches continuing medical education for doctors in diabetes and hormonal disorders Lectures for bioengineer students Leader of the 'Biochemical endocrinology and metabolism research group' at Oslo University Hospital Reviewer for multiple international journals since 2006 Expert for Norwegian Medicines Agency and EMA (2013–2020) Labs and Research Groups: Hormone Laboratory, Aker Hospital / Oslo University Hospital Biochemical Endocrinology and Metabolism Research Group, OUS

Xinping Zhangمشاهده پروفایل

استاد

• Bone Tissue Engineering
• Skeletal Repair Mechanisms
• Stem Cell Biology
• +۴ مورد دیگر

Xinping Zhang, B.Med., Ph.D., is a Professor in the Department of Orthopaedics at the University of Rochester School of Medicine & Dentistry, affiliated with the Center for Musculoskeletal Research and the UR Stem Cell and Regenerative Medicine Institute. His research focuses on molecular mechanisms of skeletal repair in bone loss due to trauma, tumors, and grafts. He holds a B.Med. from Shanghai Medical University and a Ph.D. in Biochemistry from the University of Rochester (1999). Key research interests include periosteum-mediated repair, mesenchymal stem cell differentiation, and tissue engineering strategies for bone regeneration. Notable projects involve engineering vascularized periosteum mimetics, analyzing osteogenesis-angiogenesis interfaces via multiphoton imaging, and overcoming fibrotic responses in allograft repair. Awards: MTF J.R. Neff Award (2008), Orthopaedic Research Society New Investigator Recognition Award (2005), Travel Fellowship Award (2002). Lab Team: Includes postdocs (e.g., Xiaojie Xing), research staff (Samantha Mill, Jessica Ritz), and alumni contributors like Chen Jiang and Sharif Siddiqui. Grants: Funded by NIH, NYSTEM, and foundations. His lab develops biomimetic scaffolds, investigates stem cell signaling pathways, and employs advanced imaging techniques to understand repair dynamics. Current collaborations aim to translate findings into clinical solutions for large bone defects.

Pinar Zorlutunaمشاهده پروفایل

استاد

• Bioengineering
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Pinar Zorlutuna is the Roth-Gibson Professor of Bioengineering and Director of the Bioengineering Graduate Program at the University of Notre Dame, within the College of Engineering and the Department of Chemical and Biomolecular Engineering. She leads a dynamic research lab focused on bio-inspired systems for disease modeling and regenerative medicine. Research Interests: Her work centers on tissue engineering, genetic engineering, and micro/nanotechnology to create biomimetic models of human tissues. Key areas include aging, cancer (particularly breast), and cardiovascular disease. Her lab investigates cell-cell and cell-matrix interactions, with emphasis on extracellular vesicles, the cardiac microenvironment, and 3D bioprinting. The recent publications highlight a strong trend toward modeling age-related disease progression, especially in cardiac and breast tissue. Many studies explore how aging alters the extracellular matrix and vesicle cargo, influencing disease outcomes and drug responses. Another major theme is bio-inspired computing, with research on cardiac muscle cell-based networks for biocomputing and memory systems. Elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows National Academy of Sciences Kavli Fellow Roth-Gibson Professor of Bioengineering Member, NIH CSR Cellular and Molecular Technologies Study Section NSF CAREER Award NSF EFRI BEGIN Award Dr. Zorlutuna advises graduate students and leads major federally funded grants focused on aging heart models and cardiac biocomputing. Her lab, the Zorlutuna Lab, develops innovative tools such as 3D bioprinted tissue models, microfluidic devices, and bio-oscillatory networks. Future work includes advancing real-time diagnostic platforms, personalized tissue models, and implantable biocomputational systems.

Shayn Peirce-Cottlerمشاهده پروفایل

استاد

• Systems Bioengineering
• Tissue Engineering
• Regenerative Medicine
• +۳ مورد دیگر

Shayn Peirce-Cottler is a Professor and Chair of Biomedical Engineering at the University of Virginia. Her research integrates computational modeling, experimental biology, and machine learning to study microvascular regeneration and tissue engineering. She focuses on engineering capillaries to improve therapies for conditions like fibrosis and diabetes-related vascular dysfunction. Dr. Peirce-Cottler teaches courses in systems bioengineering and cell physiology, and has published over 125 peer-reviewed works. She directs the Peirce-Cottler Lab and the UVA Center for Advanced Biomanufacturing, emphasizing translational research and technology development. Education: B.S., Johns Hopkins University (1997) Ph.D., University of Virginia (2002) Postdoctoral Fellowship, University of Virginia (2004) Research Interests: Her work spans systems bioengineering, regenerative medicine, and advanced biomanufacturing. Key projects include computational modeling of microvascular networks, 3D bioprinting for tissue repair, and developing biomaterials for wound healing. Recent studies investigate pericyte dynamics in Alzheimer’s/diabetes comorbidity and fibrotic disease mechanisms. Awards & Recognition: Harrison Distinguished Teaching Professor (2021) UVA Robert H. Kader Teaching Award (2020) Fellow of AIMBE (2016) and BMES (2020) Grants & Projects: Active funding includes NIH R21EB035402 (biomanufacturing of tissue assembloids) and R01HL155143 (lung fibrosis modeling). She co-leads the NIH T32HL007284 cardiovascular training grant. Labs & Initiatives: Directs the Peirce-Cottler Lab and co-leads the UVA Center for Advanced Biomanufacturing. Engages in K-12 STEM outreach programs to promote diversity in science education.

Carlos Eduardo Seminoمشاهده پروفایل

دانشیار

• Bioengineering
• Pharmaceutical Chemistry
• Stem Cell Research
• +۴ مورد دیگر

Carlos Eduardo Semino is an Associate Professor in the Department of Bioengineering at IQS School of Engineering , part of Universidad Ramon Llull (URL) in Spain. He holds a PhD in Chemistry (1994) and a Summa cum laude B.S. in Chemistry (1990) from the University of Buenos Aires, Argentina.

Alexander Revzinمشاهده پروفایل

استاد

• Biomedical Engineering
• Microfluidics
• Biosensors
• +۱۲ مورد دیگر

Alexander Revzin, Ph.D., is a Professor of Biomedical Engineering at Mayo Clinic in Rochester, Minnesota, with a primary appointment as a Consultant in the Department of Physiology & Biomedical Engineering and a joint appointment in the Division of Gastroenterology and Hepatology, Department of Internal Medicine. He leads the Cellular Microsystems and Biosensors Laboratory, a multidisciplinary team developing microphysiological systems (organs-on-chip) to study liver fibrosis, stem cell biology, and biosensor applications. Department: Department of Physiology & Biomedical Engineering School: Mayo Clinic College of Medicine and Science Research Lab: Cellular Microsystems and Biosensors Laboratory Email: revzin.alexander@mayo.edu Dr. Revzin's research lies at the intersection of engineering and biology, with a focus on microfabrication, microfluidics, biosensors, and regenerative medicine. His lab develops innovative platforms for cell cultivation and analysis, including liver-on-chip devices, stem cell spheroid systems, and biosensors for inflammatory cytokines and metabolites. These tools aim to model liver injury, improve stem cell differentiation, and enable point-of-care diagnostics, particularly for infectious diseases and liver conditions. The 15 most recent publications (2023–2025) reflect a strong trend toward personalized medicine, organ-on-chip modeling, and biosensor integration. Key themes include microencapsulation of stem cell-derived tissues, microfluidic organoids for cancer therapy testing, extracellular vesicle analysis, and real-time monitoring of cellular function. His work spans high-impact journals in bioengineering, materials science, and translational medicine. Scientific awards and professional recognition include: Fellow, American Institute for Medical and Biological Engineering (AIMBE), 2015 Program Director, Nano-Biosensing, National Science Foundation, 2013–2014 Chancellor’s Fellow, University of California, 2012 Associate Editor, Microsystems & Nanoengineering (Nature group journal), 2014–present Dr. Revzin actively mentors a large team of researchers and students, with frequent co-authorship from lab members such as Gwon K, de Hoyos-Vega JM, Gonzalez-Suarez AM, and Stybayeva G. His lab is equipped for microfabrication, cell culture, and biosensor development, supporting both basic and translational research. While no explicit grant details are listed, his leadership in major journals and multi-institutional collaborations suggests strong funding support. The Cellular Microsystems and Biosensors Laboratory fosters interdisciplinary collaboration, integrating mechanical, chemical, and biomedical engineers with chemists and biologists to advance regenerative medicine and diagnostic technologies.

• Epigenomics
• Cancer Biology
• Stem Cell Biology
• +۷ مورد دیگر

Dr. Alexandre Gaspar Maia is an Associate Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic, Rochester, Minnesota. He leads the Functional Epigenomics Laboratory within the Center for Individualized Medicine, focusing on epigenomic profiling and cancer stem cell research. His academic roles include serving as Associate Director of the Epigenomics Program and holding appointments in Pharmacology. Education : Ph.D. in Molecular Biology, University of Coimbra (2010) Postdoctoral Fellowship in Chromatin Biology, Icahn School of Medicine at Mount Sinai (2016) Bachelor of Science in Aquatic Sciences, University of Porto (2002) Research Interests : Epigenomics, cancer stem cells, tumor heterogeneity, ovarian cancer, single-cell sequencing technologies (RNA-seq, ATAC-seq), CRISPR/Cas9-based mechanisms, and microfluidic organoid cultures. His work integrates advanced sequencing and bioinformatics to target transcriptional dependencies in cancer. Professional Highlights : Recipient of multiple awards, including the Career Enhancement Program Award (Breast SPORE, 2022–2024) and DoD Ovarian Cancer Academy Junior Investigator (2021–2025). Developed novel methodologies for single-cell multi-omics analysis and functional validation of epigenetic regulators. Lab & Collaborations : Directs the Functional Epigenomics Lab, collaborating on projects involving tumor heterogeneity, personalized medicine, and regenerative sciences curriculum development. Active in initiatives like the Mayo Clinic Comprehensive Cancer Center and Molecular Pharmacology research programs.

• Molecular Biology
• Cell Biology
• Microbiology
• +۹ مورد دیگر

Dipl.-Ing. Manuel Reithofer Ph.D. is a researcher at the Institute of Molecular Biotechnology within the Department of Biotechnology and Food Science at the University of Natural Resources and Life Sciences, Vienna . His work focuses on molecular biology, cell biology, and microbiology, with a strong emphasis on recombinant protein production and immune response mechanisms. Education: Ph.D. in Immunology (2014-2018), Medical University of Vienna. Master in Medical Biotechnology (2012-2014), University of Natural Resources and Life Sciences, Vienna. Bachelor in Food Science and Biotechnology (2009-2012), University of Natural Resources and Life Sciences, Vienna. Dr. Reithofer's research explores baculovirus-mediated gene delivery (BacMam platform), SARS-CoV-2 spike protein interactions, and allergen-specific immunotherapy. He leads the REMBAC project (2025-2026, funded by FFG) and contributes to SARS-CoV-2 biosensor development (2021-2023, FWF). His work spans collaborations with institutions like the Medical University of Vienna. He has presented at international conferences (e.g., Protein Expression in Animal Cells (PEACe), Sitges 2023 ) and maintains affiliations with multiple BOKU research teams.

Anne Dejeanمشاهده پروفایل

استاد

• Epigenetics and gene regulation
• Chromatin biology
• Cell identity and cellular plasticity
• +۹ مورد دیگر

Anne Dejean is a leading research scientist and Professor at the Institut Pasteur in Paris, where she leads the 'Régulation Spatiale des Génomes' (Spatial Regulation of Genomes) laboratory within the Department of Genomes and Genetics. Her work bridges fundamental epigenetics with translational applications in cancer and regenerative medicine. She is Principal Investigator of multiple high-profile projects, including ERC-AdG SUMOSTRESS and ERC-AdG SUMiDENTITY, focusing on the role of SUMOylation in chromatin regulation, cell identity, and disease. Her research interests center on understanding the epigenetic and cellular mechanisms governing normal and pathological cell fates, with a strong emphasis on early embryonic development and cancer. Key areas include: Sumoylation as a guardian of cellular identity Chromatin dynamics in transcriptional regulation Cellular plasticity in development and tumorigenesis Reprogramming of cancer cells Development of synthetic embryos Molecular epidemiology of hepatocellular carcinoma The recent publications highlight a strong trend in using cutting-edge molecular and genomic techniques—such as single-cell 'omics', genome editing, and chromatin biochemistry—to explore how SUMOylation regulates cell fate transitions. Her work spans from basic mechanisms in stem cells to clinical applications in liver cancer, particularly in understudied populations with Indigenous American ancestry. The integration of synthetic biology, epigenetics, and disease modeling underscores a multidisciplinary approach aimed at developing novel therapeutic strategies. Anne Dejean has received significant research funding from the European Research Council and leads a dynamic team of researchers. She actively mentors PhD students and postdoctoral fellows, contributing to the training of the next generation of scientists. Her laboratory is involved in several collaborative initiatives, including the 'Initiative Cellules Souches' and 'Initiative Cancer' at the Institut Pasteur, reflecting her engagement in large-scale interdisciplinary efforts in stem cell biology and oncology.

Howard Matthewمشاهده پروفایل

استاد

• Tissue Engineering
• Polymeric Biomaterials
• Stem Cells for Regenerative Medicine
• +۷ مورد دیگر

Howard Matthew is a Professor in the Department of Chemical Engineering and Materials Science at Wayne State University. His research focuses on tissue engineering and regenerative medicine using polymeric biomaterials and stem cells. Collaborations include the Children's Hospital of Michigan for pediatric cardiovascular applications. Ph.D., Wayne State University (Chemical Engineering, 1992) Postdoctoral, Harvard Medical School & Massachusetts General Hospital (1994) His work spans cardiovascular tissue engineering (heart valves, blood vessels), bone and liver regeneration, and 3D tissue models for metabolic studies. Key innovations include modular scaffold systems and computational fluid dynamics for oxygenation optimization. Recent publications highlight advancements in mesenchymal stem cell assembly , liver tissue transport analysis , and biomechanical modeling of cartilage degeneration. Awards include NSF CAREER funding and recognition as a Fellow in AIMBE. 2011 Fellow of the American Institute of Medical and Biological Engineering 1996-2000 NSF CAREER Award 1992-1994 Harvard Postdoctoral Fellowship He teaches graduate and undergraduate courses in transport phenomena, process dynamics, and microfluidic systems. Collaborations with Children's Hospital of Michigan target pediatric cardiovascular implants.

Joachim Fandreyمشاهده پروفایل

استاد

• Oxygen-dependent gene expression
• Cellular oxygen sensors
• Hypoxia-inducible factors (HIF)
• +۵ مورد دیگر

Prof. Joachim Fandrey serves as the Director of the Institute of Physiology at the University Hospital Essen, affiliated with the University of Duisburg-Essen. His research group investigates oxygen-dependent gene expression , focusing on hypoxia-inducible factors (HIF), cellular oxygen sensing mechanisms, and their roles in inflammation, angiogenesis, and tissue regeneration. Institution: University of Duisburg-Essen, Institute of Physiology Contact: Joachim.Fandrey@uni-due.de Research Themes: The group explores how HIF complexes regulate gene expression under hypoxia, mechanisms of inflammatory reactions, cross-talk between hypoxia and cytokine signaling, and artificial oxygen carriers for clinical applications. Recent work includes studies on HHT (hereditary hemorrhagic telangiectasia) and DFG-funded projects. Scientific Trends: Analysis of 15 recent publications reveals a focus on hypoxia signaling in immune cells, artificial oxygen carriers, neurogenesis after ischemia, and HIF's role in cancer, inflammation, and retinal metabolism. Key subfields include ciliary oxygen sensing, NK cell hypoxia adaptation, and erythropoietin regulation. Training & Collaboration: The group includes postdocs, doctoral students, and technical staff (e.g., Anna Wrobeln, Tristan Leu, Sandra Winning, Yves Schild). They collaborate with institutions like the German Research Foundation (DFG) and participate in international symposia (e.g., Young Physiologists' Symposium).

Joana M. Ramisمشاهده پروفایل

مدرس ارشد

• Regenerative Medicine
• Cellular and Tissue Engineering
• Extracellular Vesicles
• +۶ مورد دیگر

Joana M. Ramis is a Senior Lecturer at the Department of Fundamental Biology and Health Sciences, Faculty of Health Sciences, University of the Balearic Islands (UIB). She holds a PhD in Biochemistry and Molecular Biology and has built a distinguished career in regenerative medicine and cellular engineering, with over 60 research articles, 3 patents, and leadership in 10 R&D projects as principal investigator. Bachelor in Pharmacy, University of Barcelona (1998) Bachelor in Biochemistry, University of the Balearic Islands (2002) PhD in Biochemistry and Molecular Biology, UIB (2003) Marie Curie Intra-European Fellowship, The Gurdon Institute, University of Cambridge (2004–2006) Her research focuses on cell-free regenerative medicine using extracellular vesicles derived from various cell types, aiming to develop novel therapies for tissue repair and clinical translation. She has pioneered work in scalable production, functional characterization, and therapeutic applications of extracellular vesicles in bone regeneration, wound healing, and autoimmune diseases. The analysis of her recent publications reveals a strong emphasis on translational regenerative medicine , with recurring themes in extracellular vesicle engineering , immunomodulation , biomarker discovery , and clinical standardization . Her work bridges molecular biology with biotechnological innovation, often exploring how vesicles can be optimized for targeted delivery and disease modification. She has received multiple recognitions from the Balearic Government for her excellence in teaching, research, and technology transfer: 3 teaching five-year periods recognized 3 research six-year periods recognized Remuneration complements for teaching stimulation, research activity, research excellence, and knowledge transfer Multiple prizes for scientific and entrepreneurial achievements Joana M. Ramis actively supervises PhD students and post-doctoral researchers, having directed 8 PhD theses. She has participated in 30 R&D projects and 21 industry contracts, reflecting strong collaboration between academia and biotech. She also co-founded a biotechnology company, Numat Biomedical S.L., where she served as R&D Director from 2009 to 2014. Her work continues to influence both academic research and clinical applications in regenerative medicine. She is a key contributor to the scientific community as a reviewer for international journals and remains deeply engaged in advancing the field through innovation, education, and technology transfer.

• Cancer Biomechanics
• 3D Tumor Models
• Cell Mechanics
• +۴ مورد دیگر

Dr. Anna Taubenberger leads the Oncomechanics research group at Dresden University of Technology's Center for Molecular and Cellular Bioengineering (BIOTEC). Her lab focuses on the biomechanical properties of cancer cells and their microenvironment, investigating how mechanical changes influence metastatic potential. Her research interests center on cancer biomechanics and 3D tumor modeling . The Taubenberger Group develops physiologically relevant 3D in vitro models informed by mechanical characterization of tumor samples. They systematically study how cell and microenvironment stiffness affect tumor spheroid growth, invasion, drug resistance, and metastasis using atomic force microscopy and real-time deformability cytometry. Key research aims include understanding how cells sense mechanical properties in 3D environments and identifying clinical biomarkers for breast cancer therapy. The group's publication trends reveal consistent focus on mechanical aspects of cancer progression across multiple systems. Recent work demonstrates how growth in stiff microenvironments causes compressive stress on breast cancer spheroids, altering cytoskeleton organization and slowing cell cycle progression. Their research bridges biomechanics, cancer biology, and tissue engineering to uncover novel therapeutic approaches. Awards: DFG postdoctorial fellowship Early career fellowship, QUT Australia Dr. Taubenberger mentors multiple PhD students including Vaibhav Mahajan and Mathilde Lettinga. Her research receives funding from European and German institutions, supporting projects on tumor mechanics and metastasis. The lab maintains collaborations across international institutions and utilizes advanced bioengineering approaches to create humanized models for metastasis studies. Current work focuses on identifying how cells sense mechanical environments in 3D and translating these findings toward clinical applications. The Oncomechanics lab operates within Dresden's BIOTEC center, utilizing state-of-the-art facilities for biomechanical characterization. The team includes PhD students, technical staff, and guest scientists working collaboratively on cancer mechanics projects. Their engineered tumor microenvironments enable systematic investigation of mechanical factors influencing cancer progression under controlled conditions.

Peter Zandstraمشاهده پروفایل

استاد

• Stem Cell Bioengineering
• Hematopoietic System
• Cellular Therapeutics
• +۷ مورد دیگر

Dr. Peter Zandstra is a Professor at the University of British Columbia, holding affiliations with the Michael Smith Laboratories (MSL), School of Biomedical Engineering, and Department of Medical Genetics. His research focuses on stem cell bioengineering, particularly in generating functional tissues from stem cells with applications in blood diseases and regenerative medicine. He leads four core research pillars: multi-scale simulation, synthetic cell control, niche engineering, and cellular therapeutics. His work bridges computational modeling, experimental biology, and translational medicine. Dr. Zandstra holds prestigious titles including Fellow of the Canadian Academy of Health Sciences (CAHS), Fellow of the Royal Society of Canada (FRSC), and Member of the Order of Canada (CM). His lab has secured significant funding from organizations like the Stem Cell Network and has spun out companies like Notch Therapeutics. Recent breakthroughs include computational models predicting cell fate dynamics and discoveries about 'elite clones' in stem cell reprogramming. Education: PhD in Biomedical Engineering (not explicitly stated in text) Research Themes: Hematopoietic systems, gene regulatory networks, cell competition, and personalized medicine Awards: Killam Prizes, CAHS Fellowship, Order of Canada Lab facilities include advanced cell culture systems, bioreactors, and imaging tools. Collaborations with industry and academic institutions drive preclinical trials and therapeutic development. Dr. Zandstra actively mentors trainees and promotes interdisciplinary research in regenerative medicine.

• B-cell Malignancies
• Skeletal Stem Cell Biology
• Bone Development
• +۳ مورد دیگر

Dr. Stuart Lanham is a Research Fellow in the Cancer B-Cell Group at the Institute of Developmental Sciences, University of Southampton. His work spans B-cell malignancies and skeletal stem cell biology , with a focus on translational research bridging oncology, developmental biology, and biomaterials engineering. Key research interests include: Chronic Lymphocytic Leukemia (CLL) pathogenesis B-cell receptor signaling Skeletal stem cell isolation using nanotechnology Bone development in fetal models His recent publications highlight collaborations with leading researchers like Francesco Forconi and Richard Oreffo , with studies on venetoclax therapy , nanocomposite scaffolds , and single-cell RNA-seq applications. He supervises Luis Del Rio Fernandez , a PhD student in Cancer Sciences, and contributes to interdisciplinary projects such as the ECRIN-M3 network (Cancer Research UK-funded).